Status:

COMPLETED

Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy

Lead Sponsor:

Spanish Oncology Genito-Urinary Group

Conditions:

Metastatic Renal Cell Carcinoma

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this retrospective observational study was to analyze the effect of targeted therapies administered as second-line treatment after failure of pazopanib as well as increase the amount of...

Eligibility Criteria

Inclusion

  • Patients ≥ 18.
  • Metastatic renal cell cancer of any histology.
  • Patients treated with pazopanib for metastatic cell renal cancer outside the context of clinical trials (clinical practice) in Spanish centers from 1 April 2011 until 30 June 2014. shall be included all patients who received pazopanib as first-line treatment in each participating center, whether had experienced treatment failure with pazopanib or were still in first-line treatment. The inclusion of patients who are also allowed received cytokine as first-line treatment followed by pazopanib as well as patients who received sunitinib as first-line treatment and have changed pazopanib for toxicity or intolerance, provided they have not received more a cycle of sunitinib.
  • Centers that agree to participate must commit to: · Include all patients meeting the inclusion criteria to reduce by possible selection bias. Because it supplies only pazopanib Hospital pharmacy service (not outside hospitals), the identification of patients will be performed at the hospital pharmacy records in each participating center.

Exclusion

  • Patients who received pazopanib in clinical trials or treatment second line, with the exceptions noted above.
  • Patients with the diagnosis and / or treatment of malignancies of importance other than Cell renal cancer.

Key Trial Info

Start Date :

October 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 1 2015

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT02282579

Start Date

October 1 2014

End Date

April 1 2015

Last Update

April 26 2018

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

Hospital Son Espases

Palma de Mallorca, Mallorca, Spain

2

Hospital Clínic de Barcelona

Barcelona, Spain

3

Hospital Vall d' Hebron

Barcelona, Spain

4

Hospital San Pedro de Alcántara

Cáceres, Spain